|
Market Closed -
Australian S.E.
09:18:37 09/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0110 AUD | 0.00% |
|
0.00% | -26.67% |
| 08-26 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 6.49M 4.65M 4.01M 3.8M 3.44M 6.45M 444M 45.08M 17.33M 226M 17.47M 17.09M 714M | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.3M 5.24M 4.51M 4.27M 3.87M 7.26M 500M 50.73M 19.51M 254M 19.66M 19.23M 804M | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
95.37% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUXF | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript : Acrux Limited
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 16/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| Current month | +4.76% | ||
| 1 month | +22.22% | ||
| 3 months | -35.29% | ||
| 6 months | -15.38% | ||
| Current year | -26.67% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.14 | |
| 10 years | 0.01 | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -24.14% | -74.42% | 4.65M | ||
| -1.13% | -3.11% | +13.82% | +60.66% | 46.21B | ||
| -1.13% | -5.78% | +33.26% | +108.13% | 38.78B | ||
| +0.12% | -0.08% | +7.12% | +78.27% | 11.68B | ||
| -0.53% | -1.37% | -13.25% | +10.18% | 11.55B | ||
| -0.38% | -2.26% | +18.18% | +139.63% | 9.14B | ||
| +0.32% | -2.26% | +23.08% | +34.73% | 7.3B | ||
| +0.17% | -0.74% | +13.44% | +197.13% | 7.15B | ||
| -1.00% | -5.25% | +34.34% | -19.63% | 7.1B | ||
| -3.13% | -4.30% | -44.88% | +11.66% | 4.97B | ||
| Average | -0.67% | -2.33% | +6.10% | +54.64% | 14.39B | |
| Weighted average by Cap. | -0.86% | -3.27% | +16.05% | +75.65% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.49M 3.22M 2.77M 2.63M 2.38M 4.47M 308M 31.19M 11.99M 156M 12.09M 11.82M 494M | 6.58M 4.72M 4.07M 3.85M 3.49M 6.55M 451M 45.73M 17.59M 229M 17.73M 17.34M 725M |
| Net income | -5.94M -4.26M -3.67M -3.48M -3.15M -5.92M -407M -41.31M -15.89M -207M -16.01M -15.66M -655M | -604K -433K -373K -353K -320K -601K -41.39M -4.2M -1.61M -21.05M -1.63M -1.59M -66.53M |
| Net Debt | 2.77M 1.99M 1.71M 1.62M 1.47M 2.76M 190M 19.26M 7.41M 96.63M 7.47M 7.3M 305M | 813K 583K 502K 476K 431K 809K 55.71M 5.65M 2.17M 28.34M 2.19M 2.14M 89.55M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | A$0.0110 | 0.00% | 2,843,866 |
| 08/09/26 | A$0.0110 | 0.00% | 388,905 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















